At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 741 enrolled
Drug / intervention
IDP-126 Gel +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
In Brief
A Phase 2 clinical trial evaluating IDP-126 Gel, IDP-126 Component A, and 3 other interventions for Acne Vulgaris. Completed, enrolled 741 participants across 34 sites in 2 countries.
Detailed Summary
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesCanada, United States
Collaborators--
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartOct 2017
Primary CompletionApr 2019
TodayJul 2026
First PostedMay 31, 2017
Enrollment StartOct 5, 2017
Primary CompletionApr 23, 2019
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 9.1 years ago
Interventions
IDP-126 Geldrug
Gel
IDP-126 Component Adrug
Component A
IDP-126 Component Bdrug
Component B
IDP-126 Component Cdrug
Component C
IDP-126 Vehicle Geldrug
Vehicle Gel